https://blog.dpath.ai 2026-03-13T23:01:57.000Z daily 1.0 https://blog.dpath.ai/cancer-pathology 2026-03-11T23:01:25.000Z weekly 0.9 https://blog.dpath.ai/clinical-guidelines 2026-03-13T23:01:57.000Z weekly 0.9 https://blog.dpath.ai/clinical-research 2026-01-19T01:16:51.000Z weekly 0.9 https://blog.dpath.ai/trial-analysis 2026-03-13T23:01:57.000Z weekly 0.9 https://blog.dpath.ai/hashtags 2026-03-13T23:01:57.000Z weekly 0.9 https://blog.dpath.ai/feed/41 2026-03-13T23:01:57.000Z weekly 0.8 DPathBlog en Updated NCCN Guidelines for Vaginal Cancer (Version 2.2026): What Patients Should Know 2026-03-13T23:01:57.000Z https://blog.dpath.ai/feed/40 2026-03-12T22:59:31.000Z weekly 0.8 DPathBlog en Brain metastases and targeted radiation: what new research means for patients 2026-03-12T22:59:31.000Z https://blog.dpath.ai/feed/39 2026-03-11T23:01:25.000Z weekly 0.8 DPathBlog en Vein Contact in Resectable Pancreatic Cancer: Mayo Clinic Study on Neoadjuvant Chemotherapy 2026-03-11T23:01:25.000Z pancreatic cancer, PDAC, resectable, vein abutment, neoadjuvant chemotherapy https://blog.dpath.ai/feed/38 2026-03-11T04:02:38.000Z weekly 0.8 DPathBlog en Liver Cancer Treatment Gaps: How Trust, Discrimination, and Communication Affect Who Gets Treated 2026-03-11T04:02:38.000Z https://blog.dpath.ai/feed/37 2026-03-09T23:00:12.000Z weekly 0.8 DPathBlog en PSMA PET scans and salvage radiation after prostate surgery: what five years of data show 2026-03-09T23:00:12.000Z https://blog.dpath.ai/feed/36 2026-03-08T22:59:23.000Z weekly 0.8 DPathBlog en Inherited gene mutations and cancer risk: what updated screening guidelines mean for you 2026-03-08T22:59:23.000Z https://blog.dpath.ai/feed/35 2026-03-07T16:06:35.000Z weekly 0.8 DPathBlog en Hodgkin lymphoma treatment in 2026: what the updated NCCN guidelines mean for patients 2026-03-07T16:06:35.000Z https://blog.dpath.ai/feed/34 2026-03-06T17:11:20.000Z weekly 0.8 DPathBlog en Non-small cell lung cancer: What patients need to know (2025/2026 NCCN guidelines) 2026-03-06T16:05:58.000Z nccn, lung-cancer, nsclc, patient-education https://blog.dpath.ai/feed/33 2026-03-06T12:36:07.000Z weekly 0.8 DPathBlog en Breast Cancer: What patients need to know (2025/2026 NCCN guidelines) 2026-03-06T12:36:07.000Z https://blog.dpath.ai/comprehensive-guide-breast-cancer-cns-metastases-2026 2026-02-10T06:28:01.000Z weekly 0.8 DPathBlog en 2026 Update: Comprehensive Guide to Breast Cancer Brain Metastases Treatment 2026-02-10T06:10:47.000Z breast cancer brain metastasis, her2 positive cns treatment, tucatinib success rates, t-dxd brain mets, leptomeningeal disease breakthrough https://blog.dpath.ai/cytokine-storm-explained-for-cancer-patients 2026-01-19T01:16:51.000Z weekly 0.8 DPathBlog en Cytokine Storm Explained for Cancer Patients: Symptoms, Tests, Treatment 2026-01-19T01:09:34.000Z cytokine storm, cytokine release syndrome, crs, cancer, car t cell therapy https://blog.dpath.ai/bladder-cancer-advances-patient-guide-2026 2026-01-08T01:23:28.000Z weekly 0.8 DPathBlog en Bladder Cancer Treatment Advances 2026: Immunotherapy & Bladder Sparing 2026-01-08T01:15:18.000Z localized bladder cancer, nmibc treatment, mibc treatment, bcg unresponsive, nadofaragene firadenovec https://blog.dpath.ai/multiple-myeloma-nccn-guidelines-2026 2026-01-08T00:40:02.000Z weekly 0.8 DPathBlog en 2026 NCCN Multiple Myeloma Guidelines: Patient Guide & New Treatments 2026-01-08T00:40:02.000Z nccn guidelines 2026, multiple myeloma https://blog.dpath.ai/NCCN_Basal_Cell_Skin_Cancer_2026 2026-01-08T00:33:11.000Z weekly 0.8 DPathBlog en Understanding Basal Cell Skin Cancer: A Patient’s Guide to the 2026 NCCN Guidelines 2026-01-08T00:33:11.000Z nccn basal cell skin cancer, bcc https://blog.dpath.ai/feed/27 2026-01-04T01:18:03.000Z weekly 0.8 DPathBlog en glioblastoma-simple-guide-2026 2026-01-04T01:08:28.000Z what is glioblastoma, glioblastoma explained simply, gbm for families, idh-wildtype meaning, glioblastoma treatment 2026 https://blog.dpath.ai/cancer-vaccines-future-immunotherapy-explaine 2026-01-01T00:19:18.000Z weekly 0.8 DPathBlog en Cancer Vaccines Explained: The Future of Immunotherapy for Patients (2026 Update) 2026-01-01T00:19:18.000Z cancer vaccines, therapeutic cancer vaccines, immunotherapy explained, mrna cancer vaccine, personalized cancer treatment https://blog.dpath.ai/oncolytic-viruses-cancer-treatment-explained 2025-12-31T02:32:12.000Z weekly 0.8 DPathBlog en Oncolytic Viruses & Cancer: A Patient's Guide to the Science and Terminology 2025-12-31T02:32:12.000Z oncolytic virus, cancer immunotherapy, tumor microenvironment, t-vec, checkpoint inhibitors https://blog.dpath.ai/neutrophil-extracellular-traps-cancer-patient-guide 2025-12-27T10:32:40.000Z weekly 0.8 DPathBlog en What Are Neutrophil Extracellular Traps (NETs)? How Immune "Spider Webs" Fuel Cancer & New Treatments (2025 Guide) 2025-12-27T10:32:40.000Z neutrophil extracellular traps cancer, nets in cancer explained, cancer metastasis mechanism, immune system cancer shielding, h3clip blood test https://blog.dpath.ai/feed/23 2025-12-30T09:04:48.000Z weekly 0.8 DPathBlog en Understanding Cell-Free DNA: How Liquid Biopsies Work | Patient Guide 2025-12-24T02:16:38.000Z cfdna, cell-free dna, liquid biopsy, cancer detection, dna clearance https://blog.dpath.ai/understanding-antibody-drug-conjugates-patient-guide 2025-12-30T09:37:30.000Z weekly 0.8 DPathBlog en Antibody-Drug Conjugates (ADCs) Explained: A Patient's Guide to Smart Cancer Drugs 2025-12-16T14:56:18.000Z antibody-drug conjugates, adc, cancer treatment, targeted therapy, immunotherapy https://blog.dpath.ai/unlocking-nkg2d-cancer-immunity 2025-12-09T03:08:06.000Z weekly 0.8 DPathBlog en NKG2D and MICA/B: How Immunotherapy Restores the Body's Cancer Radar 2025-12-09T03:08:06.000Z nkg2d receptor, mica/b ligands, cancer immunotherapy, natural killer cells, tumor evasion https://blog.dpath.ai/understanding-cytokines-cancer-immunotherapy 2025-11-28T12:49:03.000Z weekly 0.8 DPathBlog en Cytokines and Cancer: A Patient's Guide to Immunotherapy's Next Frontier 2025-11-28T12:49:03.000Z cytokines cancer, immunotherapy, interferon, interleukin, il-2 https://blog.dpath.ai/engineered-nk-cells-a-new-army-against-cancer 2025-11-07T02:53:30.000Z weekly 0.8 DPathBlog en Engineered NK Cells: A Patient's Guide to the Next Wave of Cancer Immunotherapy 2025-11-07T02:53:30.000Z car-nk cell therapy, natural killer cells, cancer immunotherapy, off-the-shelf cell therapy, cancer treatment for patients https://blog.dpath.ai/vax-innate-smarter-cancer-vaccine-strategy 2025-11-04T06:56:24.000Z weekly 0.8 DPathBlog en What is Vax-Innate? A New Strategy to Make Cancer Vaccines Work for Advanced Cancer 2025-11-04T06:52:08.000Z therapeutic cancer vaccine, neoantigen vaccine, vax-innate, tumor microenvironment, tme https://blog.dpath.ai/a-patient-guide-to-therapeutic-cancer-vaccines 2025-12-29T05:19:12.000Z weekly 0.8 DPathBlog en Cancer Vaccines Explained: A Guide for Patients on How They Work 2025-11-04T05:42:34.000Z cancer vaccine, therapeutic cancer vaccine, immunotherapy for cancer, cancer treatment, mrna cancer vaccine https://blog.dpath.ai/understanding-nccn-guidelines-liver-cancer-patient-guide 2025-11-03T02:09:21.000Z weekly 0.8 DPathBlog en A Comprehensive Guide to NCCN Liver Cancer Treatment Guidelines for Patients 2025-11-03T02:09:21.000Z liver cancer, hepatocellular carcinoma, nccn guidelines, liver cancer treatment, liver cancer diagnosis https://blog.dpath.ai/understanding-nccn-colon-cancer-guidelines 2025-11-03T02:05:21.000Z weekly 0.8 DPathBlog en Understanding Your Colon Cancer Journey: A Plain-English Guide to NCCN Guidelines 2025-11-03T02:05:21.000Z colon cancer, nccn guidelines, colon cancer treatment, stage 4 colon cancer, dmmr https://blog.dpath.ai/understanding-nccn-guidelines-metastatic-breast-cancer 2025-11-03T01:54:19.000Z weekly 0.8 DPathBlog en A Clear Guide to NCCN Guidelines for Metastatic Breast Cancer | For Patients 2025-11-03T01:54:19.000Z metastatic breast cancer, stage 4 breast cancer, nccn guidelines, breast cancer treatment, hormone receptor positive https://blog.dpath.ai/understanding-nccn-guidelines-metastatic-lung-cancer-patient-guide 2025-11-03T01:48:01.000Z weekly 0.8 DPathBlog en A Patient's Guide to NCCN Guidelines for Metastatic Lung Cancer | Understanding Your Treatment 2025-11-03T01:44:43.000Z metastatic non-small cell lung cancer, nccn guidelines, lung cancer treatment, targeted therapy, immunotherapy https://blog.dpath.ai/ctdna-guided-bladder-cancer-therapy 2025-11-02T15:09:05.000Z weekly 0.8 DPathBlog en ctDNA Blood Test Guides Bladder Cancer Immunotherapy After Surgery 2025-11-02T15:09:05.000Z bladder cancer, ctdna, liquid biopsy, atezolizumab, immunotherapy https://blog.dpath.ai/understanding-stage-3-nsclc-treatment 2025-10-31T02:33:10.000Z weekly 0.8 DPathBlog en New Hope for Stage 3 Lung Cancer - A Patient's Guide to the Latest Treatments 2025-10-31T02:10:12.000Z unresectable stage 3 lung cancer, non-small cell lung cancer, nsclc, durvalumab, pacific trial https://blog.dpath.ai/understanding-precancer-diagnosis 2025-10-29T02:16:23.000Z weekly 0.8 DPathBlog en What 'Precancer' Means: A Patient's Guide to a Confusing Diagnosis 2025-10-29T02:16:23.000Z precancer, precancerous condition, cancer prevention, active surveillance, watchful waiting https://blog.dpath.ai/new-hope-in-pancreatic-cancer-understanding-your-tumors-neighborhood 2025-10-29T01:37:31.000Z weekly 0.8 DPathBlog en A Patient's Guide to the Newest Pancreatic Cancer Research: The Tumor Microenvironment 2025-10-29T01:37:31.000Z pancreatic cancer patient guide, tumor microenvironment, tme, immunotherapy for pancreatic cancer, pancreatic cancer vaccine https://blog.dpath.ai/understanding-cancer-drug-resistance 2025-10-29T01:25:05.000Z weekly 0.8 DPathBlog en Understanding Cancer Drug Resistance: Why Treatment Stops Working & What's Next 2025-10-29T01:25:05.000Z multidrug resistance in cancer, cancer treatment stopped working, chemotherapy resistance, targeted therapy resistance, cancer biomarkers https://blog.dpath.ai/kras-g12d-cancer-treatment-guide 2025-10-28T13:32:07.000Z weekly 0.8 DPathBlog en A Patient's Guide to New KRAS G12D Cancer Drugs 2025-10-28T13:05:53.000Z kras g12d, cancer, targeted therapy, clinical trials, new cancer treatment https://blog.dpath.ai/new-hope-car-t-therapy-solid-tumors 2025-10-28T12:52:13.000Z weekly 0.8 DPathBlog en A New Hope: How CAR T-Cell Therapy is Finally Working for Solid Tumors 2025-10-28T12:46:11.000Z car t-cell therapy, solid tumors, cancer treatment, immunotherapy, clinical trials https://blog.dpath.ai/understanding-liquid-biopsy-mrd-cancer-treatment 2025-10-28T12:03:27.000Z weekly 0.8 DPathBlog en A New Blood Test to Fight Cancer Recurrence: Understanding MRD and Liquid Biopsy 2025-10-28T12:03:27.000Z minimal residual disease, mrd, liquid biopsy, ctdna, circulating tumor dna https://blog.dpath.ai/a-new-frontier-in-cancer-treatment-in-vivo-car-t-therapy 2025-10-28T11:55:48.000Z weekly 0.8 DPathBlog en In Vivo CAR-T: A New, Simpler Cancer Treatment on the Horizon 2025-10-28T11:43:10.000Z car-t, in vivo, cancer treatment, immunotherapy, clinical trials https://blog.dpath.ai/in-vivo-car-t-cell-engineering-for-cancer-patients 2025-10-28T09:33:40.000Z weekly 0.8 DPathBlog en In Vivo CAR T-Cell Therapy: A New Hope for Cancer Patients 2025-10-28T09:33:40.000Z car t-cell therapy, in vivo, cancer treatment, immunotherapy, gene therapy https://blog.dpath.ai/targetingMMRd 2025-10-28T08:18:29.000Z weekly 0.8 DPathBlog en MMRd Cancer Explained: A Patient's Guide to Immunotherapy Treatment 2025-10-28T06:58:43.000Z mmrd, mmrd cancer, msi-h, msi-h cancer, mismatch repair deficiency https://blog.dpath.ai/feed/1 2025-12-29T05:21:49.000Z weekly 0.8 DPathBlog en Cancer Immunotherapy: A New Way to Fight Tumors by Targeting Tregs 2025-10-28T00:50:07.000Z cancer treatment, immunotherapy, tregs, regulatory t cells, cancer research